ArticleHeliyon2025

Efficacy and safety of Janus kinase inhibitors in the treatment of psoriasis and psoriatic arthritis: An analysis of evidence from 2014 to 2022.

Jiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.